Skip to main content
SpringerLink
Log in

IGF-I/IGFBP-3 Equilibrates Ratios of Pro- to Anti-inflammatory Cytokines, Which Are Predictors for Organ Function in Severely Burned Pediatric Patients

  • Published:
Molecular Medicine Aims and scope Submit manuscript

Abstract

Background

We hypothesized that ratios of pro- to anti-inflammatory cytokines can be associated with hepatic, cardiac, and renal function after a severe trauma and can be used as predictors for clinical outcome. Furthermore, insulin-like growth factor-I (IGF-I) in combination with its principle binding protein (IGFBP-3) equilibrates proto anti-inflammatory cytokine ratios and improves homeostasis of severely burned pediatric patients.

Materials and Methods

Seventeen severely burned children were given a continuous infusion of IGF-I/BP-3 for 5 days after wound excision and grafting; seven were given saline during the same time period to serve as controls. Patient demographics and mortality were determined. Five days after excision and grafting, cardiac function was determined and blood samples were taken for serum levels of IGF-I, IGFBP-3, creatinine, pre-albumin, cholinesterase, pro-inflammatory cytokines (IL-1β, IL-6, and TNF), and anti-inflammatory cytokines (IL-2, IL-4, IL-10 and IFN-γ).

Results

There were no differences between IGF-I/BP-3 and controls in age, gender, burn size, or mortality. Serum IGF-I in burned children given the IGF-I/BP-3 complex increased from 102 ± 15 to 433 ± 33 µg/ml and IGFBP-3 increased from 1.5 ± 0.2 to 3.0 ± 0.2 µg/ml (p < 0.05). Serum pre-albumin and cholinesterase increased with IGF-I/BP-3, whereas serum creatinine decreased when compared to controls (p < 0.05). IGF-I/BP-3 increased cardiac index by 16% and stroke volume index by 15% (p < 0.05). These improvements in organ homeostasis were associated with decreased ratios of pro- to anti-inflammatory cytokines in the IGF-I/BP-3 group when compared to controls (p < 0.05).

Conclusions

Increased ratios of pro- to anti-inflammatory cytokines may indicate a higher risk for the incidence of multi-organ failure. We therefore suggest that ratios of pro-inflammatory to anti-inflammatory cytokines can be used to predict organ function. We further conclude that IGF-I/BP-3 equilibrates the balance between pro- and anti-inflammatory cytokines, which was associated with improved cardiac, renal, and hepatic function. The benefit of IGF-I/BP-3 in ameliorating the inflammatory response may also apply in reducing the multi-organ failure often observed in the state of severe trauma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Pinsky MR, Vincent JL, Deviere J. (1993) Serum cytokine levels in human septic shock: relation to multiple system organ failure and mortality. Chest 103: 565–575.

    Article  CAS  Google Scholar 

  2. Tracey KJ, Fong Y, Hesse DG, et al. (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330: 662–664.

    Article  CAS  Google Scholar 

  3. Moshage H. (1997) Cytokines and the hepatic acute phase response. J. Pathol. 181: 257–266.

    Article  CAS  Google Scholar 

  4. Jeschke MG, Wolf SE, DebRoy MA, Herndon DN. (1999) The combination of growth hormone with hepatocyte growth factor alters the acute phase response. Shock 12: 181–187.

    Article  CAS  Google Scholar 

  5. Livingston DH, Mosenthal AC, Deitch EA. (1995) Sepsis and multiple organ dysfunction syndrome: a clinical-mechanistic overview. New Horizons 3: 276–287.

    Google Scholar 

  6. Selzman CH, Shames BD, Miller SA, et al. (1998) Therapeutic implications of interleukin-10 in surgical disease. Shock 10: 309–318.

    Article  CAS  Google Scholar 

  7. De Maio A, de Mooney ML, Matesic LE, Paidas CN, Reeves RH. (1998) Genetic component in the inflammatory response induced by bacterial lipopolysaccharide. Shock 10: 319–323.

    Article  Google Scholar 

  8. Pruitt JH, Copeland EM, Moldawer LL. (1995) Interleukin-1 and interleukin-1 antagonism in sepsis systemic inflammatory response syndrome and septic shock. Shock 3: 235–251.

    Article  CAS  Google Scholar 

  9. Williams G, Giroir B. (1995) Regulation of cytokine gene expression: tumor-necrosis factor, interleukin-1, and the emerging biology of cytokine receptors. New Horizons 2: 276–287.

    Google Scholar 

  10. de Waal Malefyt R, Abrams J, Bennett B. (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulation role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209–1220.

    Article  Google Scholar 

  11. Kusske AM, Rongione AJ, Reber HA. (1996) Cytokines and acute pancreatitis. Gastroenterology 110: 639–642.

    Article  CAS  Google Scholar 

  12. Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, Kurokawa A. (1999) Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit. Care Med. 27: 1262–1264.

    Article  CAS  Google Scholar 

  13. Simovic MO, Bonham MJ, Abu-Zidan FM, Windsor JA. (1999) Anti-inflammatory cytokine response and clinical outcome in acute pancreatitis. Crit. Care Med. 27: 2662–2665.

    Article  CAS  Google Scholar 

  14. Humbel RE. (1990) Insulin-like growth factor-I and factor-II. Eur. J. Biochem. 190: 445–462.

    Article  CAS  Google Scholar 

  15. Baxter RC. (1990) Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex. J. Clin. Endocrinol. Metab. 70: 1347–1353.

    Article  CAS  Google Scholar 

  16. Clemmons DR. (1994) Insulin-like growth factor-1 as an anabolic agent in catabolic states. Ann Intern Med 120: 596–597.

    Google Scholar 

  17. Bondy CA, Underwood LE, Clemmons DR. (1994) Clinical uses of insulin-like growth factor-I. Ann. Intern. Med. 120: 593–601.

    Article  CAS  Google Scholar 

  18. Huang KF, Chung DH, Herndon DN. (1993) Insulin-like growth factor-1 (IGF-I) reduces gut atrophy and bacterial translocation after severe burn injury. Arch. Surg. 128: 47–54.

    Article  CAS  Google Scholar 

  19. Steenfos HH. (1994) Growth factors and wound healing. Scand. J. Plast. Reconstr. Hand Surg. 28: 95–105.

    Article  CAS  Google Scholar 

  20. Herndon DN, Ramzy PI, DebRoy MA, Wolf SE. (1999) Effects of insulin-like growth factor in combination with insulin-like growth factor binding protein-3 in severely burned children. Ann. Surg. 229: 713–720.

    Article  CAS  Google Scholar 

  21. Michelopoulos GK, DeFrances M. (1997) Liver regeneration. Science 276: 60–66.

    Article  Google Scholar 

  22. Jeschke MG, Herndon DN, Barrow RE. (2000) Insulin-like growth factor I in combination with insulin-like growth factor binding protein 3 affects the hepatic acute phase response and hepatic morphology in thermally injured rats. Ann. Surg. 231: 408–416.

    Article  CAS  Google Scholar 

  23. Jabri N, Schalch DS, Schwartz SL. (1994) Adverse effects of recombinant human insulin-like growth factor-I in obese insulin-resistant type II diabetic patients. Diabetes 43: 369–374.

    Article  CAS  Google Scholar 

  24. Beutler B, Milsark IW, Cerami AC. (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229: 869–871.

    Article  CAS  Google Scholar 

  25. Alexander HR, Doherty GM, Buresh CM. (1991) A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J. Exp. Med. 173: 1029–1032.

    Article  CAS  Google Scholar 

  26. Thissen JP, Verniers J. (1997) Inhibition by interleukin-1β and tumor necrosis factor-α of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture. Endocrinology 138: 1078–1084.

    Article  CAS  Google Scholar 

  27. Lang CH, Fan J, Cooney R, Vary TC. (1996) IL-1 receptor antagonist attenuates sepsis-induced alterations in the IGF system and protein synthesis. Am. J. Physiol. 270: E430–E437.

    CAS  PubMed  Google Scholar 

  28. Delhanty PJ. (1998) Interleukin-1 beta suppresses growth hormone-induced acid-labile subunit mRNA levels and secretion in primary hepatocytes. Biochem. Biophys. Res. Commun. 243: 269–272.

    Article  CAS  Google Scholar 

  29. Salgame P, Abrams JS, Clayberger C, et al. (1991) Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254: 279–282.

    Article  CAS  Google Scholar 

  30. Kelley KW, Meier WA, Minshall C, et al. (1998) Insulin growth factor-I inhibits apoptosis in hematopoietic progenitor cells. Implications in thymic aging. Ann. N.Y. Acad. Sci. 840: 518–524.

    Article  CAS  Google Scholar 

  31. Gilpin DA, Hsieh CC, Kuninger DT, Herndon DN, Papaconstantinou J. (1996) Effect of thermal injury on the expression of transcription factors that regulate acute phase response genes: the response of C/EBPα, C/EBPβ, and C/EBPδ to thermal injury. Surgery 119: 674–683.

    Article  CAS  Google Scholar 

  32. Alam T, An MR, Papaconstantinou J. (1992) Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response. J. Biol. Chem. 267: 5021–5024.

    CAS  PubMed  Google Scholar 

  33. Umayahara Y, Ji C, Centrella M, Rotwein P, McCarthy TL. (1997) CCAAT/enhancer-binding protein delta activates insulin-like growth factor-I gene transcription in osteoblasts. Identification of a novel cyclic AMP signaling pathway in bone. J. Biol. Chem. 272: 31793–31800.

    Article  CAS  Google Scholar 

  34. Nolten LA, Steenbergh PH, Sussenbach JS. (1995) Hepatocyte nuclear factor 1 alpha activates promoter 1 of the human insulin-like growth factor I gene via two distinct binding sites. Mol. Endocrinol. 9: 1488–1499.

    CAS  PubMed  Google Scholar 

  35. Nolten LA, van Schaik FM, Steenbergh PH, Sussenbach JS. (1994) Expression of the insulin-like growth I gene is stimulated by the liver-enriched transcription factors C/EBP alpha and LAP. Mol. Endocrinol. 8: 1636–1645.

    CAS  PubMed  Google Scholar 

  36. Siebenlist U, Franzoso G, Brown K. (1994) Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10: 405–455.

    Article  CAS  Google Scholar 

  37. Dinarello CA. (1996) Biologic basis for interleukin-1 in disease. Blood 87: 2095–2147.

    CAS  PubMed  Google Scholar 

  38. Kishimoto T, Taga T, Akira S. (1994) Cytokine signal transduction. Cell 76: 325–328.

    Article  Google Scholar 

Download references

Acknowledgment

This study was supported by the Shriners Hospital for Children, Grant #8660 and 8490, NIH Grants 1 RO1-GM56687-01 and 5 T32 GM 0825607, and Celtrix Pharmaceutical Company.

Author information

Authors and Affiliations

  1. Department of Surgery, University of Regensburg, Regensburg, Germany

    Marc G. Jeschke MD, PhD

  2. Shriners Hospital for Children and Department of Surgery, University Texas Medical Branch, Galveston, Texas, USA

    Marc G. Jeschke MD, PhD, Robert E. Barrow, Jyoti Rai, Deb Benjamin & David N. Herndon

  3. Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA

    Fujiyo Suzuki

  4. Klinik und Poliklinik für Chirurgie, Klinikum der Universität Regensburg, Franz-Joseph-Strauss-Allee 11, 93053, Regensburg, Germany

    Marc G. Jeschke MD, PhD

Authors
  1. Marc G. Jeschke MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert E. Barrow
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fujiyo Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jyoti Rai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Deb Benjamin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. David N. Herndon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marc G. Jeschke MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jeschke, M.G., Barrow, R.E., Suzuki, F. et al. IGF-I/IGFBP-3 Equilibrates Ratios of Pro- to Anti-inflammatory Cytokines, Which Are Predictors for Organ Function in Severely Burned Pediatric Patients. Mol Med 8, 238–246 (2002). https://doi.org/10.1007/BF03402149

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03402149

Keywords

Search

Navigation